Advertisement
Canada markets closed
  • S&P/TSX

    24,102.71
    -60.12 (-0.25%)
     
  • S&P 500

    5,695.94
    -55.13 (-0.96%)
     
  • DOW

    41,954.24
    -398.51 (-0.94%)
     
  • CAD/USD

    0.7344
    +0.0002 (+0.03%)
     
  • CRUDE OIL

    76.70
    -0.44 (-0.57%)
     
  • Bitcoin CAD

    85,021.26
    -1,880.29 (-2.16%)
     
  • XRP CAD

    0.72
    -0.01 (-1.33%)
     
  • GOLD FUTURES

    2,660.10
    -5.90 (-0.22%)
     
  • RUSSELL 2000

    2,193.09
    -19.71 (-0.89%)
     
  • 10-Yr Bond

    4.0260
    +0.0450 (+1.13%)
     
  • NASDAQ futures

    19,980.50
    -12.25 (-0.06%)
     
  • VOLATILITY

    22.64
    +3.43 (+17.86%)
     
  • FTSE

    8,303.62
    +22.99 (+0.28%)
     
  • NIKKEI 225

    39,026.15
    -306.59 (-0.78%)
     
  • CAD/EUR

    0.6684
    -0.0004 (-0.06%)
     

Amphastar: Q1 Earnings Snapshot

RANCHO CUCAMONGA, Calif. (AP) — RANCHO CUCAMONGA, Calif. (AP) — Amphastar Pharmaceuticals Inc. (AMPH) on Wednesday reported first-quarter net income of $43.2 million.

The Rancho Cucamonga, California-based company said it had net income of 81 cents per share. Earnings, adjusted for one-time gains and costs, were $1.04 per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 77 cents per share.

The specialty pharmaceutical company posted revenue of $171.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $171.1 million.

Amphastar shares have dropped 32% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $42.11, an increase of 16% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMPH at https://www.zacks.com/ap/AMPH